First trimester combined screening for Trisomy 21 in Hong Kong: Outcome of the first 10,000 cases

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 22, Issue 4, 2009, Pages 300-304

  Leung, Tak Yeung ^a   Chan, Lin Wai ^a   Law, Lai Wa ^a   Sahota, Daljit Singh ^a   Fung, Tak Yuen ^a   Leung, Tse Ngong ^b   Lau, Tze Kin ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

Chinese; Free human chorionic gonadotropin; Nuchal translucency; Pregnancy associated plasma protein A; Screening; Trisomy 21

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ALGORITHM; ARTICLE; CHROMOSOME ABERRATION; FALSE POSITIVE RESULT; FEMALE; FETUS; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; HONG KONG; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY OUTCOME; PRIORITY JOURNAL; TRISOMY 13; TRISOMY 18; TRISOMY 21; ASIAN; DOWN SYNDROME; PREDICTION AND FORECASTING; PREGNANCY; PRENATAL DIAGNOSIS; PROSPECTIVE STUDY;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DOWN SYNDROME; FEMALE; GENETIC SCREENING; HONG KONG; HUMANS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES;

EID: 67651070877     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050802430842     Document Type: Article

References (25)

1. Gilbert RE, Augood C, Gupta R, Ades AE, Logan S, Sculpher M, van Der Meulen JH. Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. BMJ 2001;323:423-425.
2. Nicolaides KH. First-trimester screening for chromosomal abnormalities. Semin Perinatol 2005;29:190-194.
3. von Kaisenberg CS, Gasiorek-Wiens A, Bielicki M, Bahlmann F, Meyberg H, Kossakiewicz A, Pruggmayer M, Kamin G, Fritzer E, Harris C, et al. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study. J Matern Fetal Neonatal Med 2002;12:89-94.
4. Stenhouse EJ, Crossley JA, Aitken DA, Brogan K, Cameron AD, Connor JM. First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice. Prenat Diagn 2004;24:774-780.
5. Wøjdemann KR, Shalmi AC, Christiansen M, Larsen SO, Sundberg K, Brocks V, Bang J, Nørgaard-Pedersen B, Tabor A. Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women. Ultrasound Obstet Gynecol 2005;25:227-233.
6. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, et al. First-trimester or second trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353: 2001-2011.
7. Hadlow NC, Hewitt BG, Dickinson JE, Jacoby P, Bower C. Community-based screening for Down's Syndrome in the first trimester using ultrasound and maternal serum biochemistry. BJOG 2005;112:1561-1564.
8. Leung TY, Chan LW, Leung TN, Fung TY, Sahota DS, Spencer K, Lau TK. First-trimester combined screening for trisomy 21 in a predominantly Chinese population. Ultrasound Obstet Gynecol 2007;29:14-17.
9. Leung TY, Spencer K, Leung TN, Fung TY, Lau TK. Higher median levels of free b-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down's syndrome in the Chinese population. Fetal Diagn Ther 2006;21: 140-143.
10. Spencer K. Screening for trisomy 21 in twin pregnancies in the first trimester: does chorionicity impact on maternal serum free b-hCG or PAPP-A levels? Prenat Diagn 2001;21: 715-717.
11. Avgidou K, Papageorghiou A, Bindra R, Spencer K, Nicolaides KH. Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. Am J Obstet Gynecol 2005;192:1761-1767.
12. FMF Regulations for Certification in the 11-13+6 weeks scan. http://www.fetalmedicine.com/f-downs.htm.
13. Caughey AB, Kuppermann M, Norton ME, Washington AE. Nuchal translucency and first trimester biochemical markers for down syndrome screening: a costeffectiveness analysis. Am J Obstet Gynecol 2002;187: 1239-1245.
14. Chan YM, Leung TN, Leung TY, Fung TY, Chan LW, Lau TK. The utility assessment of Chinese pregnant women towards the birth of a baby with Down syndrome compared to a procedure-related miscarriage. Prenat Diagn 2006;26: 819-824.
15. Kuppermann M, Nease RF, Learman LA, Gates E, Blumberg B, Washington AE. Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's p. Obstet Gynecol 2000; 96:511-516.
16. Grobman WA, Dooley SL, Welshman EE, Pergament E, Calhoun EA. Preference assessment of prenatal diagnosis for Down syndrome: is 35 years a rational cutoff? Prenat Diagn 2002;22:1195-1200.
17. Leung TN, Chau MCM, Chang JJ, Leung TY, Fung TY, Lau TK. Attitudes towards termination of pregnancy among Hong Kong Chinese women attending prenatal diagnosis counseling clinic. Prenat Diagn 2004;24:546-551.
18. Drake H, Reid M, Marteau T. Attitudes towards termination for fetal abnormality: comparisons in three European countries. Clin Genet 1996;49:134-140.
19. de Graaf IM, Tijmstra T, Bleker OP, van Lith JM. Womens' preference in Down syndrome screening. Prenat Diagn 2002;22:624-629.
20. Spencer K, Aitken D. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies. Ultrasound Obstet Gynecol 2004;24:735-739.
21. Leung TY. First trimester combined screening for Down syndrome: experience from Hong Kong. In: The 20th Asian and Oceanic Congress of Obstetrics and Gynaecology; 2007 September 21-25; Tokyo. Abstract book; 122p.
22. Chan LW, Chau MC, Leung TY, Fung TY, Leung TN, Lau TK. Expectation and knowledge of women undergoing first-trimester combined screening for Down syndrome in a Chinese population. Prenat Diagn 2005;25:1248-1252.
23. Lau TK, Leung TY, Fung TY, Chan LW, Sahota DS, Leung TN. Outcome of 1355 consecutive transabdominal chorionic villus samplings in 1351 patients. CMJ 2005;20: 1675-1681.
24. Snijders RJ, Sebire NJ, Nicolaides KH. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther 1995;10:356-367.
25. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, et al. First-trimester maternal serum PAPP-A and free-b subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004;191:1446-1451.